These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
216 related articles for article (PubMed ID: 15569926)
1. A critical role for p27kip1 gene dosage in a mouse model of prostate carcinogenesis. Gao H; Ouyang X; Banach-Petrosky W; Borowsky AD; Lin Y; Kim M; Lee H; Shih WJ; Cardiff RD; Shen MM; Abate-Shen C Proc Natl Acad Sci U S A; 2004 Dec; 101(49):17204-9. PubMed ID: 15569926 [TBL] [Abstract][Full Text] [Related]
2. Pten and p27KIP1 cooperate in prostate cancer tumor suppression in the mouse. Di Cristofano A; De Acetis M; Koff A; Cordon-Cardo C; Pandolfi PP Nat Genet; 2001 Feb; 27(2):222-4. PubMed ID: 11175795 [TBL] [Abstract][Full Text] [Related]
3. Nkx3.1 and p27(KIP1) cooperate in proliferation inhibition and apoptosis induction in human androgen-independent prostate cancer cells. Wang P; Ma Q; Luo J; Liu B; Tan F; Zhang Z; Chen Z Cancer Invest; 2009 May; 27(4):369-75. PubMed ID: 19266349 [TBL] [Abstract][Full Text] [Related]
4. Genetic rescue of cell number in a mouse model of microphthalmia: interactions between Chx10 and G1-phase cell cycle regulators. Green ES; Stubbs JL; Levine EM Development; 2003 Feb; 130(3):539-52. PubMed ID: 12490560 [TBL] [Abstract][Full Text] [Related]
5. Antitumoral activity of lenalidomide in in vitro and in vivo models of mantle cell lymphoma involves the destabilization of cyclin D1/p27KIP1 complexes. Moros A; Bustany S; Cahu J; Saborit-Villarroya I; Martínez A; Colomer D; Sola B; Roué G Clin Cancer Res; 2014 Jan; 20(2):393-403. PubMed ID: 24178620 [TBL] [Abstract][Full Text] [Related]
6. The concurrent expression of p27(kip1) and cyclin D1 in epithelial ovarian tumors. Sui L; Tokuda M; Ohno M; Hatase O; Hando T Gynecol Oncol; 1999 May; 73(2):202-9. PubMed ID: 10329035 [TBL] [Abstract][Full Text] [Related]
7. [Effect of allitridi on cyclin D1 and p27(Kip1) protein expression in gastric carcinoma BGC823 cells]. Lan H; Lu YY Ai Zheng; 2003 Dec; 22(12):1268-71. PubMed ID: 14693049 [TBL] [Abstract][Full Text] [Related]
8. p27(Kip1) deficiency promotes prostate carcinogenesis but does not affect the efficacy of retinoids in suppressing the neoplastic process. Taylor W; Mathias A; Ali A; Ke H; Stoynev N; Shilkaitis A; Green A; Kiyokawa H; Christov K BMC Cancer; 2010 Oct; 10():541. PubMed ID: 20932324 [TBL] [Abstract][Full Text] [Related]
9. Rapid turnover of cell-cycle regulators found in Mirk/dyrk1B transfectants. Ewton DZ; Lee K; Deng X; Lim S; Friedman E Int J Cancer; 2003 Jan; 103(1):21-8. PubMed ID: 12455049 [TBL] [Abstract][Full Text] [Related]
10. Deregulated expression of p27(Kip1) in human breast cancers. Sgambato A; Zhang YJ; Arber N; Hibshoosh H; Doki Y; Ciaparrone M; Santella RM; Cittadini A; Weinstein IB Clin Cancer Res; 1997 Oct; 3(10):1879-87. PubMed ID: 9815577 [TBL] [Abstract][Full Text] [Related]
11. PI3K/Akt signaling regulates p27(kip1) expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27(kip1) regulation in LNCaP and PC346 cells. van Duijn PW; Trapman J Prostate; 2006 May; 66(7):749-60. PubMed ID: 16425184 [TBL] [Abstract][Full Text] [Related]
12. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade. Guo Y; Sklar GN; Borkowski A; Kyprianou N Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624 [TBL] [Abstract][Full Text] [Related]
13. BCR signals target p27(Kip1) and cyclin D2 via the PI3-K signalling pathway to mediate cell cycle arrest and apoptosis of WEHI 231 B cells. Banerji L; Glassford J; Lea NC; Thomas NS; Klaus GG; Lam EW Oncogene; 2001 Nov; 20(50):7352-67. PubMed ID: 11704865 [TBL] [Abstract][Full Text] [Related]
14. Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression. Fernández PL; Arce Y; Farré X; Martínez A; Nadal A; Rey MJ; Peiró N; Campo E; Cardesa A J Pathol; 1999 Apr; 187(5):563-6. PubMed ID: 10398122 [TBL] [Abstract][Full Text] [Related]
15. Increased AKT activity contributes to prostate cancer progression by dramatically accelerating prostate tumor growth and diminishing p27Kip1 expression. Graff JR; Konicek BW; McNulty AM; Wang Z; Houck K; Allen S; Paul JD; Hbaiu A; Goode RG; Sandusky GE; Vessella RL; Neubauer BL J Biol Chem; 2000 Aug; 275(32):24500-5. PubMed ID: 10827191 [TBL] [Abstract][Full Text] [Related]
16. Loss of the cell cycle inhibitors p21(Cip1) and p27(Kip1) enhances tumorigenesis in knockout mouse models. Jackson RJ; Adnane J; Coppola D; Cantor A; Sebti SM; Pledger WJ Oncogene; 2002 Dec; 21(55):8486-97. PubMed ID: 12466968 [TBL] [Abstract][Full Text] [Related]
17. Induction of cell cycle arrest and apoptosis in human prostate carcinoma cells by a recombinant adenovirus expressing p27(Kip1). Katner AL; Hoang QB; Gootam P; Jaruga E; Ma Q; Gnarra J; Rayford W Prostate; 2002 Sep; 53(1):77-87. PubMed ID: 12210483 [TBL] [Abstract][Full Text] [Related]
18. The phosphoinositide 3-kinase/Akt pathway regulates cell cycle progression of HL60 human leukemia cells through cytoplasmic relocalization of the cyclin-dependent kinase inhibitor p27(Kip1) and control of cyclin D1 expression. Cappellini A; Tabellini G; Zweyer M; Bortul R; Tazzari PL; Billi AM; Falà F; Cocco L; Martelli AM Leukemia; 2003 Nov; 17(11):2157-67. PubMed ID: 12931221 [TBL] [Abstract][Full Text] [Related]
19. Methylation and mutational analysis of p27(kip1) in prostate carcinoma. Kibel AS; Christopher M; Faith DA; Bova GS; Goodfellow PJ; Isaacs WB Prostate; 2001 Sep; 48(4):248-53. PubMed ID: 11536304 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of F-Box protein p45(SKP2) expression and stabilization of cyclin-dependent kinase inhibitor p27(KIP1) in vitamin D analog-treated cancer cells. Lin R; Wang TT; Miller WH; White JH Endocrinology; 2003 Mar; 144(3):749-53. PubMed ID: 12586749 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]